Skip to content
10-Q

Quarterly Report

Cue Biopharma, Inc. CUE

0001193125-25-277466

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 78.74M sh
Shares Diluted Q3 2025 · Sep 30, 2025 100.87M sh
Shares Diluted Q3 2025 · Sep 30, 2025 90.27M sh
Shares Diluted Q3 2025 · Sep 30, 2024 51.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 50.29M sh
Capex Q3 2025 · Sep 30, 2025 $177K
Capex Q3 2025 · Sep 30, 2024 $64K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$20.61M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$27.3M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $11.7M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $22.46M
Stockholders Equity Q3 2025 · Sep 30, 2025 $13.25M
Stockholders Equity Q3 2025 · Jun 30, 2025 $18.16M
Stockholders Equity Q3 2025 · Dec 31, 2024 $17.5M
Stockholders Equity Q3 2025 · Sep 30, 2024 $25.37M
Stockholders Equity Q3 2025 · Jun 30, 2024 $21.62M
Stockholders Equity Q3 2025 · Dec 31, 2023 $37.09M
Current Liabilities Q3 2025 · Sep 30, 2025 $15.52M
Current Liabilities Q3 2025 · Dec 31, 2024 $13.69M
Total Liabilities Q3 2025 · Sep 30, 2025 $18.4M
Total Liabilities Q3 2025 · Dec 31, 2024 $14.69M
Current Assets Q3 2025 · Sep 30, 2025 $25.82M
Current Assets Q3 2025 · Dec 31, 2024 $25.14M
Total Assets Q3 2025 · Sep 30, 2025 $31.64M
Total Assets Q3 2025 · Dec 31, 2024 $32.19M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.31
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.17
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.62
Eps Basic Q3 2025 · Sep 30, 2025 −$0.07
Eps Basic Q3 2025 · Sep 30, 2025 −$0.31
Eps Basic Q3 2025 · Sep 30, 2024 −$0.17
Eps Basic Q3 2025 · Sep 30, 2024 −$0.62
Sga Expense Q3 2025 · Sep 30, 2025 $4.94M
Sga Expense Q3 2025 · Sep 30, 2025 $12.79M
Sga Expense Q3 2025 · Sep 30, 2024 $2.87M
Sga Expense Q3 2025 · Sep 30, 2024 $10.56M
Rd Expense Q3 2025 · Sep 30, 2025 $4.75M
Rd Expense Q3 2025 · Sep 30, 2025 $21.21M
Rd Expense Q3 2025 · Sep 30, 2024 $9.38M
Rd Expense Q3 2025 · Sep 30, 2024 $29.11M
Net Income Q3 2025 · Sep 30, 2025 −$7.45M
Net Income Q3 2025 · Sep 30, 2025 −$28.19M
Net Income Q3 2025 · Sep 30, 2024 −$8.66M
Net Income Q3 2025 · Sep 30, 2024 −$31.18M
Operating Income Q3 2025 · Sep 30, 2025 −$7.6M
Operating Income Q3 2025 · Sep 30, 2025 −$28.53M
Operating Income Q3 2025 · Sep 30, 2024 −$8.82M
Operating Income Q3 2025 · Sep 30, 2024 −$31.87M
Revenue Q3 2025 · Sep 30, 2025 $2.15M
Revenue Q3 2025 · Sep 30, 2025 $5.52M
Revenue Q3 2025 · Sep 30, 2024 $3.34M
Revenue Q3 2025 · Sep 30, 2024 $7.71M